Agios Pharmaceuticals plans to share data from RISE UP with the Food and Drug Administration to support the approval of the sickle cell disease indication.

The investigational oral therapy combines doravirine, a non-nucleoside reverse transcriptase inhibitor, with islatravir, a nucleoside reverse transcriptase translocation inhibitor, in a single tablet ...

Plozasiran is an apoC-III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III ...

Lung ultrasound is acceptable diagnostic alternative to chest radiography in medical centers with appropriate clinical expertise.

Irene Papanicolas, PhD, from the Brown University School of Public Health in Providence, Rhode Island, and colleagues calculated premature mortality rates across US states and Washington, DC, for 2012 ...

Study reveals self-administered, at-home hypnosis intervention reduces mean number of hot flashes, daily interference.

With this approval, Thrombate III is the only antithrombin concentrate approved in both adults and pediatric patients with hereditary antithrombin deficiency.

COVID-19 diagnosis linked to higher risk for arterial thromboembolism, venous thromboembolism, thrombocytopenia, myocarditis or pericarditis ...

Topline data were announced from a phase 3 trial evaluating giredestrant for the adjuvant treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ...

VS-041 is an oral inhibitor of matrix metalloproteinases shown to reduce cardiac fibrosis and improve diastolic heart function in preclinical HFpEF models.

Current evidence base insufficient to definitively link acetaminophen use in pregnancy with autism, ADHD in offspring.

HealthDay News — A Washington state resident has become the first person in the US to test positive for a rare bird flu strain that has never before been found in humans. The older adult, who has ...